The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Brain region‐specific deficit in mitochondrial electron transport chain complexes in children with autism
Open accessAbstract
J. Neurochem. (2011) 117, 209–220. Mitochondria play important roles in generation of free radicals, ATP formation, and in apoptosis. We studied the levels of mitochondrial electron transport chain (ETC) complexes, that is, complexes I, II, III, IV, and V, in brain tissue samples from the cerebellum and the frontal, parietal, occipital, and temporal cortices of subjects with autism and age‐matched control subjects. The subjects were divided into two groups according to their ages: Group A (children, ages 4–10 years) and Group B (adults, ages 14–39 years). In Group A, we observed significantly lower levels of complexes III and V in the cerebellum (p < 0.05), of complex I in the frontal cortex (p < 0.05), and of complexes II (p < 0.01), III (p < 0.01), and V (p < 0.05) in the temporal cortex of children with autism as compared to age‐matched control subjects, while none of the five ETC complexes was affected in the parietal and occipital cortices in subjects with autism. In the cerebellum and temporal cortex, no overlap was observed in the levels of these ETC complexes between subjects with autism and control subjects. In the frontal cortex of Group A, a lower level of ETC complexes was observed in a subset of autism cases, that is, 60% (3/5) for complexes I, II, and V, and 40% (2/5) for complexes III and IV. A striking observation was that the levels of ETC complexes were similar in adult subjects with autism and control subjects (Group B). A significant increase in the levels of lipid hydroperoxides, an oxidative stress marker, was also observed in the cerebellum and temporal cortex in the children with autism. These results suggest that the expression of ETC complexes is decreased in the cerebellum and the frontal and temporal regions of the brain in children with autism, which may lead to abnormal energy metabolism and oxidative stress. The deficits observed in the levels of ETC complexes in children with autism may readjust to normal levels by adulthood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the cerebellum, the levels of lipid hydroperoxide [103], a product of fatty acid oxidation; of malonyldialdehyde [104], an end-product of lipid peroxidation; of 8-hydroxy-2’-deoxyguanosine (8-OH-dG) [105, 106], a marker of oxidative DNA damage; of protein carbonyl [107], a marker of protein oxidation; and of 3-nitrotyrosine [108], a marker of protein nitration, were significantly increased in”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [103]
In the citing paper
“Our studies of different brain regions showed that oxidative stress differentially affects selective brain regions, i.e., cerebellum, temporal and frontal cortices, in autism [103–105, 107]. Increased oxidative stress and mitochondrial abnormalities were not observed in the parietal and occipital cortices in autism [103–105, 107].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [103]
In the citing paper
“Reduced levels of complexes III and V in the cerebellum, of complex I in the frontal cortex, and of complexes II, III, and V in the temporal cortex were observed in children with autism as compared to age-matched control subjects [103].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial free radical generation, oxidative stress, and aging
Cadenas, E., & Davies, K. J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00317-8 · Cited by 3,010
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Histoanatomic observations of the brain in early infantile autism
Bauman, M., & Kemper, T. L. (1985) · Neurology · doi:10.1212/wnl.35.6.866 · Cited by 964
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955
Neuroanatomic observations of the brain in autism: a review and future directions
Bauman, M. L., & Kemper, T. L. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.09.006 · Cited by 919
Rice, C. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e562722010-001 · Cited by 762
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Self-citationEnergetic basis of brain activity: implications for neuroimaging
Shulman, R. G., Rothman, D. L., Behar, K. L., & Hyder, F. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.005 · Cited by 590
Research works printed but not linked: 1
- Muthaiyah B., 2009, Increased lipid peroxidation in cerebellum and temporal cortex of brain in autism, J. Neurochem., 108
Cited by
Sorted by citations
Consensus Paper: Pathological Role of the Cerebellum in Autism
Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723
Self-citationRose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T. G., Frye, R. E., & James, S. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.61 · Cited by 480
Rossignol, D. A., & Frye, R. E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00150 · Cited by 382
Oxidative stress-related biomarkers in autism: Systematic review and meta-analyses
Frustaci, A., Neri, M., Cesario, A., Adams, J. B., Domenici, E., Bernardina, B. D., & Bonassi, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.011 · Cited by 383
A mitochondrial bioenergetic etiology of disease
Wallace, D. C. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61398 · Cited by 342
Oxidative Stress in Autism Spectrum Disorder
Bjørklund, G., Meguid, N. A., El-Bana, M. A., Tinkov, A. A., Saad, K., Dadar, M., Hemimi, M., Skalny, A. V., Hosnedlová, B., Kizek, R., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01742-2 · Cited by 323
Cerebral folate receptor autoantibodies in autism spectrum disorder
Frye, R. E., Sequeira, J. M., Quadros, E. V., James, S. J., & Rossignol, D. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.175 · Cited by 257
Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245
Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder
Usui, N., Kobayashi, H., & Shimada, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065487 · Cited by 278
Glutathione redox imbalance in brain disorders
Gu, F., Chauhan, V. P. S., & Chauhan, A. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000134 · Cited by 233
Self-citationClinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
Rose, S., Niyazov, D. M., Rossignol, D. A., Goldenthal, M. J., Kahler, S. G., & Frye, R. E. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0352-x · Cited by 237
Etiology of autistic features: the persisting neurotoxic effects of propionic acid
El-Ansary, A. K., Bacha, A. B., & Kotb, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-74 · Cited by 209
Oxidative Stress in Autism Spectrum Disorder—Current Progress of Mechanisms and Biomarkers
Liu, X., Jing, L., Zhang, H., Khan, N. U., Zhang, J., Tang, X., Cao, X., & Shen, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.813304 · Cited by 201
Brain Region-Specific Glutathione Redox Imbalance in Autism
Chauhan, A., AUDHYA, T. K., & Chauhan, V. P. S. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0775-4 · Cited by 196
Self-citationMitochondrial abnormalities in temporal lobe of autistic brain
Tang, G., Gutierrez Rios, P., Kuo, S.-H., Akman, H. O., Rosoklija, G., Tanji, K., Dwork, A., Schon, E. A., DiMauro, S., Goldman, J., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.006 · Cited by 194
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 193
Zawadzka, A., Cieślik, M., & Adamczyk, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111516 · Cited by 197
Brain Transcriptional and Epigenetic Associations with Autism
Ginsberg, M. R., Rubin, R. A., Falcone, T., Ting, A. H., & Natowicz, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044736 · Cited by 164
Mitochondrial Dysfunction as a Neurobiological Subtype of Autism Spectrum Disorder
Goh, S., Dong, Z., Zhang, Y., DiMauro, S., & Peterson, B. S. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.179 · Cited by 162
Gu, F., Chauhan, V. P. S., Kaur, K., Brown, W. T., LaFauci, G., Węgiel, J., & Chauhan, A. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.68 · Cited by 160
Self-citationBrain region-specific altered expression and association of mitochondria-related genes in autism
Anitha, A., Nakamura, K., Thanseem, I., Yamada, K., Iwayama, Y., Toyota, T., Matsuzaki, H., Miyachi, T., Yamada, S., Tsujii, M., et al. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-12 · Cited by 153
Węgiel, J., Flory, M. J., Kuchna, I., Nowicki, K., Ma, S. Y., Imaki, H., Wegiel, J., Cohen, I. L., London, E., Wısnıewskı, T., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0141-7 · Cited by 153
Self-citationFrye, R. E., Rose, S., Slattery, J. M., & MacFabe, D. F. (2015) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v26.27458 · Cited by 145
Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities
Sbodio, J. I., Snyder, S. H., & Paul, B. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7321 · Cited by 149
Mitochondrial Dysfunction in Autism Spectrum Disorders
SIDDIQUI, M., Elwell, C. E., & Johnson, M. H. (2016) · Autism - Open Access · doi:10.4172/2165-7890.1000190 · Cited by 145
Wu, H., Wang, X., Gao, J., Liang, S., Hao, Y., Sun, C., Xia, W., Cao, Y., & Wu, L. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.01.012 · Cited by 137
Al-Amin, M. M., Rahman, M., Khan, F. R., Zaman, F., & Reza, H. M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.041 · Cited by 135
Nanotechnology inspired tools for mitochondrial dysfunction related diseases
Wen, R. M., Banik, B., Pathak, R., Kumar, A., Kolishetti, N., & Dhar, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.024 · Cited by 130
Potential serum biomarkers from a metabolomics study of autism
Wang, H., Liang, S., Wang, M., Gao, J., Sun, C., Wang, J., Xia, W. T., Wu, S., Sumner, S., Zhang, F., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140009 · Cited by 121
Recent Updates in the Treatment of Neurodegenerative Disorders Using Natural Compounds
Rasool, M., Malik, A., Qureshi, M. S., Manan, A., Pushparaj, P. N., Asif, M., Qazi, M. H., Qazi, A. M., Kamal, M. A., Gan, S. H., et al. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/979730 · Cited by 124
Frye, R. E., Rincon, N., McCarty, P. J., Brister, D., Scheck, A. C., & Rossignol, D. A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106520 · Cited by 132
Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives
Hollis, F., Kanellopoulos, A. K., & Bagni, C. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.05.018 · Cited by 120
Frye, R. E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.134 · Cited by 117
Napoli, E., Ross‐Inta, C., Wong, S., Hung, C., Fujisawa, Y., Sakaguchi, D., Angelastro, J. M., Omanska-Klusek, A., Schoenfeld, R. A., & Giulivi, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042504 · Cited by 116
The multifaceted role of mitochondria in autism spectrum disorder
Khaliulin, I., Hamoudi, W., & Amal, H. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02725-z · Cited by 128
Kumar, H., & Sharma, B. (2015) · Brain Research · doi:10.1016/j.brainres.2015.10.052 · Cited by 119
The glial perspective of autism spectrum disorders
Zeidán‐Chuliá, F., Salmina, A. B., Malinovskaya, N. A., Noda, M., Verkhratsky, A., & Moreira, J. C. F. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.008 · Cited by 116
Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder
Dong, D., Zielke, H. R., Yeh, D., & Yang, P. (2018) · Autism Research · doi:10.1002/aur.1966 · Cited by 116
Downregulation of the Expression of Mitochondrial Electron Transport Complex Genes in Autism Brains
Anitha, A., Nakamura, K., Thanseem, I., Matsuzaki, H., Miyachi, T., Tsujii, M., Iwata, Y., Suzuki, K., Sugiyama, T., & Mori, N. (2012) · Brain Pathology · doi:10.1111/bpa.12002 · Cited by 113
Are ASD and ADHD a Continuum? A Comparison of Pathophysiological Similarities Between the Disorders
Kern, J. K., Geier, D. A., Sykes, L. K., Geier, M. R., & Deth, R. C. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712459886 · Cited by 114
Mitochondrial function and abnormalities implicated in the pathogenesis of ASD
Castora, F. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.015 · Cited by 107
Higdon, R., Earl, R. K., Stanberry, L. I., Hudac, C. M., Montague, E., Stewart, E., Janko, I., Choiniere, J., Broomall, W., Kolker, N., et al. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0020 · Cited by 107
Evidence of parallels between mercury intoxication and the brain pathology in autism
Kern, J. K., Geier, D. A., AUDHYA, T. K., King, P. G., Sykes, L. K., & Geier, M. R. (2012) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2012-1887 · Cited by 103
The metabolic basis for developmental disorders due to defective folate transport
Desai, A., Sequeira, J. M., & Quadros, E. V. (2016) · Biochimie · doi:10.1016/j.biochi.2016.02.012 · Cited by 98
Ubiquinol Improves Symptoms in Children with Autism
Gvozdjáková, A., Kucharská, J., Ostatníková, D., Babinská, K., Nakládal, D., & Crane, F. L. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/798957 · Cited by 98
Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats
Kumar, H., & Sharma, B. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.013 · Cited by 103
Kaur, K., Chauhan, V. P. S., Gu, F., & Chauhan, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.030 · Cited by 100
Self-citationEvidence of neurodegeneration in autism spectrum disorder
Kern, J. K., Geier, D. A., Sykes, L. K., & Geier, M. R. (2013) · Translational Neurodegeneration · doi:10.1186/2047-9158-2-17 · Cited by 95
Silvestrin, R. B., Bambini-Júnior, V., Galland, F., Bobermin, L. D., Quincozes‐Santos, A., Abib, R. T., Zanotto, C., Batassini, C., Brolese, G., Gonçalves, C., et al. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.048 · Cited by 99
Mitochondrial Dysfunction in Autism
Legido, A., Jethva, R., & Goldenthal, M. J. (2013) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2013.10.008 · Cited by 90
Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder
Frye, R. E., & Rossignol, D. A. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00066 · Cited by 90
Gu, F., Chauhan, V. P. S., & Chauhan, A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.021 · Cited by 88
Self-citationKumar, H., Sharma, B. M., & Sharma, B. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.10.007 · Cited by 86
Elevated mitochondrial DNA copy number in peripheral blood cells is associated with childhood autism
Chen, S., Li, Z., Hé, Y., Zhang, F., Li, H., Liao, Y., Wei, Z., Wan, G., Xiang, X., Hu, M., et al. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0432-y · Cited by 83
Folic Acid and Autism: A Systematic Review of the Current State of Knowledge
Hoxha, B., Hoxha, M., Domi, E., Gervasoni, J., Persichilli, S., Малај, В., & Zappacosta, B. (2021) · Cells · doi:10.3390/cells10081976 · Cited by 90
Untargeted Metabolomics for Autism Spectrum Disorders: Current Status and Future Directions
Glinton, K. E., & Elsea, S. H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00647 · Cited by 79
Chua, R. X. Y., Tay, M. J. Y., Ooi, D. S. Q., Siah, K. T. H., Tham, E. H., Shek, L. P., Meaney, M. J., Broekman, B. F. P., & Loo, E. X. L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.603571 · Cited by 82
Griffiths, K. K., & Levy, R. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4314025 · Cited by 83
Zeidán‐Chuliá, F., Rybarczyk-Filho, J. L., Salmina, A. B., de Oliveira, B. H. N., Noda, M., & Moreira, J. C. F. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8224-3 · Cited by 74
Oxidative Stress and Antioxidant Pathway in Allergic Rhinitis
Han, M. S., Lee, D., Lee, S. H., & Kim, T. H. (2021) · Antioxidants · doi:10.3390/antiox10081266 · Cited by 78
Spilioti, M. G., Evangeliou, A., Tramma, D., Theodoridou, Z., Metaxas, S., Michailidi, E., Bonti, E., Fryssira, H., Haidopoulou, A., Asprangathou, D., et al. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00858 · Cited by 71
The Gut Microbiota and Oxidative Stress in Autism Spectrum Disorders (ASD)
Hu, T., Dong, Y., He, C., Zhao, M., & He, Q. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8396708 · Cited by 72
Wang, Y., Picard, M. A., & Gu, Z. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006391 · Cited by 79
Zürcher, N. R., Loggia, M. L., Mullett, J. E., Tseng, C.-E. J., Bhanot, A., Richey, L., Hightower, B. G., Wu, C. J., Parmar, A. J., Butterfield, R. I., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0682-z · Cited by 72
Schwede, M., Nagpal, S., Gandal, M. J., Parikshak, N., Mirnics, K., Geschwind, D. H., & Morrow, E. M. (2018) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-018-9237-x · Cited by 72
Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder
Gevezova, M., Sarafian, V. S., Anderson, G., & Maes, M. H. J. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200628015039 · Cited by 63
Purinergic Signaling and Energy Homeostasis in Psychiatric Disorders
Lindberg, D. M., Shan, D., Ayers-Ringler, J. R., Oliveros, A., Benitez, J. C. A., Prieto, M. L., McCullumsmith, R. E., & Choi, D. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330163724 · Cited by 65
Vuillaume, M., Naudion, S., Banneau, G., Diene, G., Cartault, A., Cailley, D., Bouron, J., Toutain, J., Bourrouillou, G., Vigouroux, A., et al. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36587 · Cited by 57
Anesthesia, brain changes, and behavior: Insights from neural systems biology
Colon, É., Bittner, E. A., Kussman, B. D., McCann, M. E., Soriano, S. G., & Borsook, D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.005 · Cited by 58
Khera, R., Mehan, S., Kumar, S., Sethi, P., Bhalla, S., & Prajapati, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02819-1 · Cited by 57
Matsuo, K., Yabuki, Y., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107975 · Cited by 53
Gevezova, M., Sbirkov, Y., Sarafian, V. S., Plaimas, K., Suratanee, A., & Maes, M. H. J. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100646 · Cited by 54
Goldenthal, M. J., Damle, S., Sheth, S., Shah, N. D., Melvin, J. J., Jethva, R., Hardison, H. H., Marks, H. G., & Legido, A. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.72 · Cited by 52
Does microglial dysfunction play a role in autism and Rett syndrome?
Maezawa, I., Calafiore, M., Wulff, H., & Jin, L. (2011) · Neuron Glia Biology · doi:10.1017/s1740925x1200004x · Cited by 53
McMeekin, L. J., Fox, S. N., Boas, S. M., & Cowell, R. M. (2021) · Cells · doi:10.3390/cells10020352 · Cited by 53
Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder
Bjørklund, G., Meguid, N. A., El-Ansary, A. K., El‐Bana, M. A., Dadar, M., Aaseth, J., Hemimi, M., Osredkar, J., & Chirumbolo, S. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1192-1 · Cited by 54
Hormesis, cellular stress response, and redox homeostasis in autism spectrum disorders
Calabrese, V., Giordano, J., Ruggieri, M., Berritta, D., Salinaro, A. T., Ontario, M. L., Bianchini, R., & Calabrese, E. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23893 · Cited by 50
Nadeem, A., Ahmad, S. F., Attia, S. M., AL-Ayadhi, L. Y., Al-Harbi, N. O., & Bakheet, S. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.020 · Cited by 50
Mitochondria and early-life adversity
Zitkovsky, E. K., Daniels, T. E., & Tyrka, A. R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.005 · Cited by 53
Wegiel, J., Flory, M., Kuchna, I., Nowicki, K., Ma, S. Y., Imaki, H., Wegiel, J., Frackowiak, J., Kolecka, B. M., Wierzba-Bobrowicz, T., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0183-5 · Cited by 47
Self-citationWang, Y., Guo, X., Hong, X., Wang, G., Pearson, C., ZUCKERMAN, B. S., Clark, A. G., O'Brien, K. O., Wang, X., & Gu, Z. (2022) · Nature Communications · doi:10.1038/s41467-022-30805-7 · Cited by 48
Hyperbaric oxygen treatment in autism spectrum disorders
Rossignol, D. A., Bradstreet, J. J., Dyke, K. V., Schneider, C., Freedenfeld, S. H., O’Hara, N., Cave, S. F., Buckley, J. A., Mumper, E. A., & Frye, R. E. (2012) · Medical Gas Research · doi:10.1186/2045-9912-2-16 · Cited by 47
Mitochondrial dysfunction in cognitive neurodevelopmental disorders: Cause or effect?
Anitha, A., Thanseem, I., Iype, M., & Thomas, S. V. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.01.002 · Cited by 47
VLDL-specific increases of fatty acids in autism spectrum disorder correlate with social interaction
Usui, N., Iwata, K., Miyachi, T., Takagai, S., Wakusawa, K., Nara, T., Tsuchiya, K. J., Matsumoto, K., Kurita, D., Kameno, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102917 · Cited by 45
Abruzzo, P. M., Mattè, A., Bolotta, A., Federti, E., Ghezzo, A., Guarnieri, T., Marini, M., Posar, A., Siciliano, A., Franceschi, L. D., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2076-z · Cited by 45
The maternal autoimmune environment affects the social behavior of offspring
Zhang, Y., Gao, D., Kluetzman, K., Mendoza, A., Bolivar, V. J., Reilly, A. A., Kasten‐Jolly, J., & Lawrence, D. A. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.02.019 · Cited by 42
Higher Lactate Level and Lactate-to-Pyruvate Ratio in Autism Spectrum Disorder
Oh, M., Kim, S. A., & Yoo, H. J. (2020) · Experimental Neurobiology · doi:10.5607/en20030 · Cited by 40
Yui, K., Sato, A., & Imataka, G. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150324122930 · Cited by 41
The Dying of the Light: Mitochondrial Failure in Alzheimer's Disease
Young, K. J., McArdle, M. J., & Bennett, J. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111487 · Cited by 39
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia
Moos, W. H., Maneta, E., Pinkert, C. A., Irwin, M. H., Hoffman, M. E., Faller, D. V., & Steliou, K. (2016) · Drug Development Research · doi:10.1002/ddr.21295 · Cited by 41
Wang, D., Jiang, Y., Jiang, J. W., Pan, Y., Yang, Y., Fang, X., Liang, L., Li, H., Dong, Z., Fan, S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101919 · Cited by 40
Vanwong, N., Srisawasdi, P., Ngamsamut, N., Nuntamool, N., Puangpetch, A., Chamkrachchangpada, B., Hongkaew, Y., Limsila, P., Kittitharaphan, W., & Sukasem, C. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00527 · Cited by 38
Hamzawy, M. A., El-Ghandour, Y. B., Abdel‐Aziem, S. H., & Ali, Z. (2018) · International Journal of Immunopathology and Pharmacology · doi:10.1177/2058738418785514 · Cited by 38
Guevara-Campos, J., González-Guevara, L., Puig-Alcaraz, C., & Cauli, O. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9419-x · Cited by 37
Ghanizadeh, A. J., Berk, M., Farrashbandi, H., Shoushtari, A. A., & Villagonzalo, K.-A. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.10.001 · Cited by 39
Autism and EMF? Plausibility of a pathophysiological link – Part I
Herbert, M. R., & Sage, C. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.08.001 · Cited by 37
Altun, H., Şahın, N., Kurutaş, E. B., Karaaslan, U., Sevgen, F. H., & Fındıklı, E. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1470360 · Cited by 36
Kartawy, M., Халиулин, И. Г., & Amal, H. (2021) · Brain Sciences · doi:10.3390/brainsci11060677 · Cited by 36
Role of NAD + , Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders
Essa, M. M., Subash, S., Braidy, N., Al‐Adawi, S., Lim, C. K., Manivasagam, T., & Guillemin, G. J. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s11355 · Cited by 41
Self-citation
Metadata
- Authors
- Chauhan, A., Gu, F., Essa, M. M., Wegiel, J., Kaur, K., Brown, W. T., & Chauhan, V.
- Affiliations
- New York State Office for People With Developmental Disabilities (US)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2011-02-24
- Volume
- 117
- Issue
- 2
- Pages
- 209-220
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- PMC
- PMC4839269
- OpenAlex
- W1577847097
- Cited by
- 243
- References
- 88
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 26 · 2023: 23 · 2022: 19 · 2021: 17 · 2020: 15 · 2019: 6 · 2018: 17 · 2017: 8 · 2016: 11 · 2015: 18 · 2014: 18 · 2013: 19 · 2012: 21
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Defense
- Office for People With Developmental Disabilities
- National Institute on Aging (P30AG008051)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, cerebellum, frontal cortex, temporal cortex, oxidative stress, lipid hydroperoxides, brain energy metabolism, children versus adults
- MeSH terms
- Adolescent, Adult, Age Factors, Autistic Disorder, Brain, Child, Child, Preschool, Female, Humans, Lipid Peroxides, Male, Multienzyme Complexes, Postmortem Changes, Case-Control Studies, Reactive Oxygen Species, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review